tirzepatide and kidney damage (Zepbound) showed improved function in obese patients with both chronic kidney disease #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Tirzepatide and Kidney Disease: Safety

However, the role of FXR in improving metabolic dysfunction is contentious, as intestine-specific FXR agonism improves the metabolic profiles of mice 274,275 and increases the expression of TGR5 276 , which mediates bile acid-induced GLP-1 secretion from EECs 277

As metabolic stability improves, appetite and cravings naturally begin to decrease

Mrunal Shirodkar +2 more Table of Contents The trend of using simple, homemade drinks to stay healthy is on the rise

While the drug labels for many GLP-1 medications mentioned common side effects like nausea, vomiting, and diarrhea, it is alleged that they failed to adequately warn of the risk of developing severe, permanent conditions like gastroparesis